Journal
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Volume 113, Issue 4, Pages 859-865Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ijrobp.2022.04.009
Keywords
-
Funding
- Genentech
- Varian
- Kroger
- NIH [R702]
Ask authors/readers for more resources
The use of Ga-68-DOTATATE PET imaging may assist radiation oncologists in creating more precise radiation treatment volumes by identifying undetected areas of disease that are not visible on MRI.
Purpose: Radiation treatment planning for meningiomas traditionally involves magnetic resonance imaging (MRI) contrast enhanced images to define residual tumor. However, the gross tumor volume may be difficult to delineate for patients with a meningioma in the skull base sagittal sinus or after resection. Advanced positron emission tomography (PET) imaging using Ga-68-DOTATATE, which has been shown to be more sensitive and specific than MRI imaging, can be used for target volume delineation in these circumstances. We hypothesized that Ga-68-DOTATATE PET scan-based treatment planning would lead to smaller radiation volumes and would detect additional areas of disease compared with standard MRI alone. Methods and Materials: Our data evaluated retrospective, deidentified, and blinded gross tumor volume contour delineation with 7 central nervous system (CNS) specialists (4 CNS radiation oncologists and 3 neuroradiologists) for 25 patients with a meningioma diagnosis who received both a Ga-68-DOTATATE PET and an MRI for radiation treatment planning. Both the MRI and the PET were nonsequentially contoured by each physician for each patient. Results: The median MRI volume for each physician ranged from 16.94-25.53 cm(3). The median PET volume for each physician ranged from 2.09 to 8.36 cm(3). The median PET volume was smaller for each physician. In addition, 7 of the 25 patients (28%) had new nonadjacent areas contoured on PET by at least 6 of the 7 physicians that were not contoured by these physicians on the corresponding MRI. These new areas would not have been in the traditional MRI-based volumes. Conclusions: Our study supports that Ga-68-DOTATATE PET imaging may help radiation oncologists create more precise radiation treatment volumes through finding undetected areas of disease not seen on MRI. Treatment planning guided by Ga-68-DOTATATE PET should be studied prospectively. (C) 2022 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available